Recent

% | $
Quotes you view appear here for quick access.

MiMedx Group, Inc. Message Board

  • earth457 earth457 Oct 18, 2013 12:41 PM Flag

    Big blocks on the ask

    Do we have a large seller? Perhaps somebody feels a less than desirable outcome with the FDA will have a pronounced impact on the stock? I've already lowered my expectations. Any positive news out of the FDA meeting will be a pleasant surprise for me.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Pete acquires another 150,000 shares - form 4 filed at 4pm market close. Something good may be happening....

    • Good for MDXG to secure a meeting with FDA a couple of days before earnings release. Worst case, If the FDA meeting goes really bad, I'd expect a press release from management asap indicating the removal of injectables to usurp any further allegations. We can price that in and await potential good news from release (3 MACs) for a nice leg up.

      The injectables are a bonus short term and the next phase for growth 5-10 years out (expect MDXG to be bought out). Amniofix is being treated like PRP with payers as "investigational" until more data is provided.

    • So, if the FDA says sell your product with close scrutiny and clinical trials. Does that affect the sales in US? Their products will be sold world wide. This is a huge new revenue stream not factored into guidance. Amniofix was only 15% of next year in US. FDA would not inhibit world sales of Amniofix.

 
MDXG
7.06-0.04(-0.56%)Aug 30 4:00 PMEDT